Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $28.20. The company's market cap stands at 160.32B, with a P/E ratio of 20.71 and a dividend yield of 6.1%.
During the trading session on 2026-04-01, Pfizer(PFE) shares reached a daily high of $28.39 and a low of $28.04. At a current price of $28.20, the stock is +0.6% higher than the low and still -0.7% under the high.
Trading volume for Pfizer(PFE) stock has reached 10.99M, versus its average volume of 42.79M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.39 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.39 and a low of $20.92.
PFE News
Wedbush analyst David Nierengarten lowered the firm’s price target on Oric Pharmaceuticals (ORIC) to $17 from $20 and keeps an Outperform rating on the shares....
Pfizer (PFE) is back in focus after reporting over 70% efficacy in a Phase 3 Lyme disease vaccine trial and positive Phase 3 results for prostate cancer therapy...
A big dividend can’t hide the growth problem at Pfizer (PFE), one of the world’s largest pharmaceutical companies. Pfizer has seen its stock rise more than 16%...
Analyst ratings
55%
of 29 ratingsMore PFE News
It is not surprising that before an earnings season, every investor looks for stocks that can beat market expectations. This is because investors always try to...
Key Points Pfizer has a proven track record of success in the pharmaceutical sector. Management has shown, once again, that it can pivot quickly when needed....
Pfizer (NYSE:PFE) reported positive Phase 2 results for atirmociclib in metastatic breast cancer. The company announced favorable Phase 3 TALAPRO-3 data for TA...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 30% Off TipRanks Premium Unlock hedge fund-lev...
Option traders moderately bearish in Pfizer (PFE), with shares down 18c near $27.39. Options volume roughly in line with average with 52k contracts traded and c...
Earlier this month, Pfizer and Valneva reported that their Phase 3 VALOR trial of the investigational 6‑valent Lyme disease vaccine showed more than 70% efficac...
Income Investors Face a Hard Truth About Pfizer’s Payout Safety By Trey Thoelcke Published Mar 26, 7:55AM EDT Quick Read Pfizer (PFE) paid $9.771B in dividend...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.